Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04751409 · ClinicalTrials.gov registry record · Phase 2

Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities

A Phase 2 study of Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 and Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
Phase 2
Development phase
227
Enrollment target
1
Study location

NCT04751409 is a Phase 2 study of Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 and Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 227 participants, above the 160-participant average among 4 other Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 trials with a reported enrollment target (42% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04751409, a Phase 2 study of Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 and Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
Phase 2
Development phase
227 participants
Enrollment target
1
Study location

Study Summary

This phase II trial studies how anxiety is affected by 2 types of follow-up after surgery, limited follow-up and intense follow-up, in patients with stage II-III soft tissue sarcoma of the trunk and extremities. In cancer survivors, the fear of cancer coming back (recurring) is common and may persist long after the end of treatment. It may also be exacerbated by return visits for imaging (surveillance). The purpose of this study is to determine how patients' anxiety and other cancer-related outcomes are affected by how often surveillance is done.

Interventions

  • PROCEDURE Computed Tomography
  • PROCEDURE Chest Radiography
  • PROCEDURE Follow-Up
  • PROCEDURE Imaging Technique

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 227 participants
Start Date 2020-12-28
Est. Completion 2027-12-31
Phase Phase 2

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT04751409

The ClinicalTrials.gov registry entry for NCT04751409 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 227 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 160-participant average among 4 other Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 trials with a reported enrollment target (42% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 appearing as the primary indexed condition, and to 4 interventions - of which Computed Tomography is the first listed.

NCT04751409 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04751409 about?

NCT04751409 is a clinical study titled "Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities". This phase II trial studies how anxiety is affected by 2 types of follow-up after surgery, limited follow-up and intense follow-up, in patients with stage II-III soft tissue sarcoma of the trunk and extremities. In cancer survivors, the fear of cancer coming back (recurring) is common and may persis...

What is the current status of trial NCT04751409?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 227 participants. The study started on 2020-12-28. Estimated completion is 2027-12-31.

What conditions does trial NCT04751409 study?

This clinical trial studies the following conditions: Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8.

What interventions are being tested in trial NCT04751409?

The interventions under investigation include: Computed Tomography (PROCEDURE), Chest Radiography (PROCEDURE), Follow-Up (PROCEDURE), Imaging Technique (PROCEDURE).

Who is sponsoring clinical trial NCT04751409?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04751409 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.